Skip to main content
Premium Trial:

Request an Annual Quote

NIH Awards $9.1M to Support Community Outreach Efforts for All of Us Program

NEW YORK — The National Institutes of Health said today that it has awarded $9.1 million in funding to two organizations to help boost community outreach efforts for the All of Us Research Program.

The program aims to enroll 1 million Americans willing to donate biological samples and share a variety of data from electronic medical records, surveys, wearables, and genetic testing that researchers can use to learn more about diseases and develop treatments. It opened up to participants last May.

NIH said it has awarded the new funding to Washington DC-based advisory firm HCM Strategists and the University of Utah, which will develop new approaches to educate communities about the All of Us initiative and to build relationships with participants.

The NIH said that HCM will leverage the partner network it previously built through the Community and Provider Gateway Initiative, which is designed to promote the inclusion of diverse populations in the All of Us initiative. The university, meantime, will use community-based participatory design techniques to develop and evaluate culturally sensitive engagement experiences, and provide insights into digital engagement and provider engagement strategies, the NIH added. 

"These awardees bring tremendous knowledge and a proven track record in community engagement, which will be critical in the program's work to foster ongoing conversations with the public and build authentic relationships over time," Dara Richardson-Heron, chief engagement officer of the All of Us Research Program, said in a statement.

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.